New pill for diabetes begins human testing
NCT ID NCT05579314
Summary
This early-stage study tested the safety and effects of a new oral medication called XW014 for type 2 diabetes. It involved 127 healthy volunteers and people with type 2 diabetes, who received either the drug or a placebo. The main goal was to see how the body processes the drug and to check for any side effects at different dose levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON - Early Development Services
Lenexa, Kansas, 66219, United States
-
ICON - Early Development Services
San Antonio, Texas, 78209, United States
-
ICON - Early Development Services
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.